Core Product & Primary Benefit
VILDMAC VM 850 is a highly effective, advanced oral medication designed for the management of Type 2 Diabetes Mellitus. This fixed-dose combination therapy brings together Vildagliptin and Metformin Hydrochloride 850 mg to provide superior glycemic control. It helps patients achieve and maintain healthy blood sugar levels when diet and exercise alone are insufficient. Choose VILDMAC VM 850 as a foundational step in your comprehensive diabetes management plan to reduce the risk of long-term complications.
Dual Mechanism of Action & Key Ingredients
Experience the synergistic power of two key agents in one tablet. Vildagliptin, a DPP-4 inhibitor, works by boosting the body's natural production of insulin and reducing the release of glucose from the liver when blood sugar is high. Complementing this, Metformin 850 mg improves the body's sensitivity to insulin and decreases glucose absorption from the food you eat. This dual-action mechanism ensures more consistent and powerful HbA1c reduction compared to monotherapy.
Target Patient Profile & Dosage
VILDMAC VM 850 is typically prescribed for adult patients with Type 2 diabetes who have not achieved adequate control with Metformin monotherapy, or who are already being treated with Vildagliptin and Metformin as separate tablets. The precise 850 mg dosage of Metformin makes it a convenient and practical option, simplifying the dosing regimen. Consult your healthcare provider to see how this combination tablet can effectively integrate into your existing diabetes treatment protocol, minimizing the fluctuation of post-meal glucose levels.
Manufacturer Trust & Availability
Trust the quality of MK Healthcare for your vital medication. VILDMAC VM 850 is manufactured adhering to stringent pharmaceutical standards, ensuring high efficacy and patient safety. Available across major pharmacies, this medication offers an accessible solution for millions of individuals battling chronic hyperglycemia. Discuss the benefits of Vildagliptin and Metformin 850 mg combination with your doctor today to take a proactive step towards better long-term diabetes care and overall health.
How does the Vildagliptin component work to lower blood sugar?
Vildagliptin is a Dipeptidyl Peptidase-4 (DPP-4) inhibitor. It works by blocking the DPP-4 enzyme, which typically breaks down incretin hormones (like GLP-1 and GIP).
By preserving these hormones, Vildagliptin helps the pancreas to release more insulin and the liver to produce less glucose, particularly after meals, thereby lowering blood sugar.
How does the Metformin 850mg component contribute to diabetes control?
Metformin 850mg works through several mechanisms: it decreases the amount of glucose produced by the liver, reduces glucose absorption from the intestines, and improves the body's sensitivity to insulin. This complements Vildagliptin's action, resulting in more comprehensive blood sugar management.
What is the best time to take VILDMAC-VM 850?
VILDMAC-VM 850 should typically be taken twice daily (morning and evening). It is generally recommended to take this medication with or immediately after meals to minimize common gastrointestinal side effects associated with Metformin.
What is the risk of Lactic Acidosis with VILDMAC-VM 850?
Metformin carries a rare but serious risk of Lactic Acidosis, which is a medical emergency. The risk increases in patients with severe kidney problems, heart failure, or those who consume excessive alcohol. Symptoms include unusual muscle pain, trouble breathing, and extreme tiredness. Inform your doctor immediately if these occur.
Why must VILDMAC-VM 850 be stopped before certain medical procedures?
VILDMAC-VM 850 (Metformin) must typically be stopped 48 hours before and after any procedure requiring the injection of an iodinated contrast agent (like a CT scan or angiogram). The contrast agent can temporarily impair kidney function, increasing the risk of Lactic Acidosis.
Does this combination cause low blood sugar (Hypoglycemia)?
When taken alone, Vildagliptin and Metformin have a low risk of causing severe hypoglycemia. However, the risk increases significantly if VILDMAC-VM 850 is taken in combination with other high-risk anti-diabetic medications like insulin or sulfonylureas.
What are the precautions for patients with kidney or liver problems?
VILDMAC-VM 850 is often not recommended for patients with moderate to severe kidney impairment due to the risk of Metformin accumulation and Lactic Acidosis. It is also generally contraindicated in severe liver disease. Your doctor must monitor your kidney and liver function regularly.
Does VILDMAC-VM 850 affect vitamin $B_{12}$ levels?
Yes, the Metformin component in VILDMAC-VM 850 may, in rare cases and particularly with long-term use, lead to reduced absorption and deficiency of Vitamin $B_{12}$. Your doctor may monitor your Vitamin $B_{12}$ levels and recommend supplementation if needed.
